Growth Metrics

Enanta Pharmaceuticals (ENTA) EPS (Weighted Average and Diluted) (QoQ) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Enanta Pharmaceuticals 367.22 Mn 203.44 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -7.14%
Dec 31, 2025 52.27%
Sep 30, 2025 -3.53%
Jun 30, 2025 19.81%
Mar 31, 2025 -0.95%
Dec 31, 2024 22.79%
Sep 30, 2024 -27.10%
Jun 30, 2024 27.21%
Mar 31, 2024 6.96%
Dec 31, 2023 -18.80%
Sep 30, 2023 28.49%
Jun 30, 2023 -3.91%
Mar 31, 2023 -28.78%
Dec 31, 2022 -9.45%
Sep 30, 2022 16.99%
Jun 30, 2022 6.13%
Mar 31, 2022 -10.14%
Dec 31, 2021 -21.31%
Sep 30, 2021 -2.52%
Jun 30, 2021 -9.17%
Mar 31, 2021 -165.85%
Dec 31, 2020 71.92%
Sep 30, 2020 -105.63%
Jun 30, 2020 -136.67%
Mar 31, 2020 -146.15%
Dec 31, 2019 47.73%
Sep 30, 2019 33.33%
Jun 30, 2019 65.00%
Mar 31, 2019 -84.00%
Dec 31, 2018 -3.85%
Sep 30, 2018 34.02%
Jun 30, 2018 59.02%
Mar 31, 2018 3.39%
Dec 31, 2017 -68.28%
Sep 30, 2017 522.73%
Jun 30, 2017 -57.14%
Mar 31, 2017 -7.69%
Dec 31, 2016 -188.89%
Sep 30, 2016 -50.00%
Jun 30, 2016 33.33%
Mar 31, 2016 -106.57%
Dec 31, 2015 372.41%
Sep 30, 2015 123.08%
Jun 30, 2015 -91.28%
Mar 31, 2015 -31.65%
Dec 31, 2014 907.41%
Sep 30, 2014 -110.34%
Jun 30, 2014 1,032.14%
Mar 31, 2014 6.67%
Dec 31, 2013 -20.00%
Sep 30, 2013 -8.70%
Jun 30, 2013 89.91%
Mar 31, 2013 -257.24%
Dec 31, 2012 130.33%
Sep 30, 2012 -10.90%
Jun 30, 2012 -298.62%